Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Prevention of Osteoporosis in Acute Rehab
NCT00421343Phase 3Completed
- Sponsor
- Hebrew SeniorLife
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of alendronate in osteoporosis, sponsored by Hebrew SeniorLife. Primary endpoint: Number Adherent With the Intervention at 6 months. Started Feb 2007; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00421343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421343.